Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,821,220
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
5,644,984
-
Shares change
-
+178
-
Total reported value, excl. options
-
$106,633,384
-
Value change
-
+$3,364
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$18.89
Significant Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q3 2025
11 filings reported holding NBTX - Nanobiotix S.A. - Common Stock as of Q3 2025.
Nanobiotix S.A. - Common Stock (NBTX) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,644,984 shares
of 46,821,220 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include JOHNSON & JOHNSON (5,623,816 shares), GEODE CAPITAL MANAGEMENT, LLC (10,184 shares), Optiver Holding B.V. (5,356 shares), MORGAN STANLEY (2,378 shares), UBS Group AG (2,161 shares), EverSource Wealth Advisors, LLC (514 shares), BNP PARIBAS FINANCIAL MARKETS (400 shares), ROYAL BANK OF CANADA (125 shares), RHUMBLINE ADVISERS (33 shares), and NATIONAL BANK OF CANADA /FI/ (13 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.